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differentiation of mouse embryonic NSCs and neurite out-
growth of NSC-derived neurons. Moreover, JNK activation 
is involved in the effects of VPA stimulation.
Keywords Neural stem cells · Valproic acid · Neuronal 
differentiation · Neurite outgrowth · JNK
Introduction
Neural stem cells (NSCs) have the ability to proliferate; 
self-renew; and differentiate into oligodendrocytes, astro-
cytes, and neurons; NSCs are also considered a potential 
therapeutic tool for treating central nervous system (CNS) 
injuries [1–3]. In NSC-based therapy, neuronal differentia-
tion is a key step in the regeneration and replacement of 
lost neurons and neural networks [4, 5]. However, NSCs 
produce only a small number of neurons under normal con-
ditions. Therefore, it is important to explore strategies to 
promote more efficient neuronal differentiation of NSCs. 
Moreover, neurite outgrowth is a key cellular aspect of neu-
ronal differentiation and is crucial for neural plasticity and 
synaptic formation [6].
At present, a multitude of factors have been shown to 
promote NSC differentiation into neurons, such as neuro-
trophin-3 (NT-3), NG2, Mash1, bone morphogenetic pro-
tein 4, and all-trans retinoic acid (RA) [7–10]; more recent 
studies reported that valproic acid (VPA), an effective and 
safe mood stabilizer that has been used in the treatment of 
bipolar diseases and different epilepsy syndromes for sev-
eral decades [11, 12]. Recently, the application of VPA has 
expanded to several clinical trials of treating HIV and vari-
ous cancers [12–14]. Furthermore, increasing in vitro and 
in  vivo evidence demonstrated that VPA acts as a neuro-
trophic compound through its ability to increase neurite 
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outgrowth, promote differentiation, protect neurons, and 
enhance neurogenesis [15–22]. Our previous study has 
observed that VPA enhanced the neuronal differentiation 
of embryonic NSCs derived from rat [16], but the relevant 
mechanisms were not explored. In addition, neuronal dif-
ferentiation of adult female Fisher 344 rats hippocampal 
neural progenitor cells (NPCs), embryonic Sprague–Daw-
ley rat-derived NPCs, 46C mouse ESC-derived NPCs, and 
spinal cord injury (SCI) rat-derived spinal neural stem/
precursor cells (NSPCs) were found to be upregulated by 
VPA [17–20]. Moreover, VPA induced neurite outgrowth 
in human mesenchymal stem cells (MSCs) and SH-SY5Y 
neuroblastoma cells [21, 22]. However, the underlying 
molecular mechanism of VPA-induced neuronal differen-
tiation and neurite outgrowth is complex and remains to be 
elucidated.
c-Jun N-terminal kinase (JNK), a subfamily of the mito-
gen-activated protein kinases (MAPKs), has a variety of 
cellular functions, including cell survival, apoptosis, and 
programmed cell death [23, 24]. Moreover, accumulating 
evidence suggests that JNK is involved in embryogenesis, 
neurite formation, neurite outgrowth, regeneration, neu-
ronal differentiation, and memory formation in the nerv-
ous system [25–28]. At present, JNK activation is reported 
to be implicated in the regulation of neuronal differentia-
tion or neurite outgrowth [29, 30]. Meanwhile, Yamauchi 
et al. reported that JNK participates in VPA-induced neur-
ite outgrowth of mouse neuroblastoma N1E-115 cells [31]. 
Therefore, it is reasonable to speculate that JNK activation 
is required for VPA-induced neuronal differentiation of 
NSCs and neurite outgrowth of NSC-derived neurons.
In this study, NSCs were obtained from the embryonic 
mouse cortex; the ability of VPA to enhance their differ-
entiation to neurons, astrocytes, or oligodendrocytes was 
determined, and neurite outgrowth of mouse NSC-derived 
neurons was assessed. Furthermore, the requirement of 
JNK activation in the neurotrophic effect of VPA on the 
neuronal differentiation of NSCs and neurite outgrowth of 
NSC-derived neurons was determined.
Materials and Methods
Animals
C57BL/6 mice were purchased from the Radiation Study 
Institute Animal Centre at Tianjin Medical University 
(Tianjin, China). All experiments were performed in 
accordance with the Ethics Committee of Tianjin Medical 
University and complied with the U.S. National Institutes 
of Health Guide for the Care and Use of Experimental Ani-
mals. Every effort was made to minimize the suffering and 
number of mice used.
Isolation and Culture of Mouse Embryonic NSCs
NSCs were isolated from mouse embryonic cortex (E13.5) 
and cultured using the method of Reynolds and Weiss [32, 
33], with slight modifications. Briefly, forebrain cortices 
were cut into small pieces, incubated with accutase (Invitro-
gen, Carlsbad, CA, USA) and triturated through a 26-gauge 
needle. The pellets were suspended in growth medium 
[Dulbecco’s modified Eagle’s medium (DMEM):F-12 
medium (DMEM/F12) (Invitrogen) supplemented with 
epidermal growth factor (EGF, 20 ng/ml), basic fibroblast 
growth factor (bFGF, 20 ng/ml), leukaemia inhibitory fac-
tor (LIF, 10 ng/ml; both from PeproTech, Rocky Hill, NJ, 
USA), heparin (2.5  μg/ml, Tocris Bioscience, Minneapo-
lis, MN, USA), 2% B27 supplement, l-glutamine (1 mM), 
penicillin and streptomycin (both 100 U/ml) (all from Invit-
rogen)]. The cells were incubated in a humidified incubator 
at 37 °C with 5%  CO2, and half the medium was exchanged 
every 2–3 days. After 5–7 days in vitro, the cells prolifer-
ated as free-floating neurospheres. Floating neurospheres 
were collected and passaged after enzymatic dissociation 
with accutase and mechanically triturated with fire-pol-
ished glass pipettes.
Cell Differentiation and Treatments
For cell differentiation, third-passage neurospheres were 
dissociated and plated 5.0 × 104/cm2 in 12-well cell culture 
plates coated with poly-l-lysine (PLL, 0.1 mg/ml, Sigma-
Aldrich, St. Louis, MO, USA) in differentiation medium 
[DMEM: F12 medium containing B27 supplement and 1% 
foetal bovine serum (FBS; Invitrogen)]. Cells were exposed 
to 1 mM VPA (Sigma-Aldrich) for up to 7 days consider-
ing that several lines of evidence have demonstrated that 
1 mM is a desirable concentration for the neuronal differ-
entiation of NPCs [16–18]. Furthermore, to investigate the 
involvement of JNK in response to VPA stimulation, the 
specific JNK inhibitor SP600125 (Calbiochem, San Diego, 
CA, USA) was suspended in dimethyl sulfoxide (DMSO; 
Sigma-Aldrich) and applied to treat NSCs with VPA at 
10  μM for 7  days after plating. As SP600125 was resus-
pended in 0.1% DMSO, an equivalent volume of DMSO 
was added to control culture medium and VPA-treated NSC 
culture medium. Therefore, three groups were included: 
DMSO-treated control culture group, VPA-treated culture 
group, and VPA plus with SP600125 culture group.
Immunocytochemistry
Immunocytochemistry was performed as described pre-
viously [16]. Cells were washed with PBS, fixed with 4% 
paraformaldehyde, permeabilized with 0.3% Triton X-100 
(Sigma-Aldrich), and blocked with 10% normal goat serum 
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(NGS; Invitrogen). Then, the cells were incubated over-
night at 4 °C with the following primary antibodies: rab-
bit anti-nestin (1:500; Sigma-Aldrich), rabbit anti-β-III-
tubulin (1:500; Covance, Princeton, NJ, USA) or rabbit 
anti-microtubule-associated protein-2 (MAP-2) (1:200; 
Millipore, Billerica, MA, USA), rabbit anti-glial fibrillary 
acidic protein (GFAP) (1:1000; Abcam, Cambridge, UK), 
and rabbit anti-CNPase (1:100; Cell Signaling Technology, 
Danvers, MA, USA). The cells were then washed with PBS 
and incubated with Alexa Fluor 555-conjugated goat anti-
rabbit (1:500; Invitrogen). 4′6′-diamidino-2-phenylindole 
(DAPI; Beijing Solarbio Science & Technology Co., Bei-
jing, China) was used to stain nuclei, and fluorescence was 
detected using a fluorescence microscope (IX71, Olympus, 
Tokyo, Japan).
Quantification of Neuronal Differentiation of NSCs 
and Neurite Outgrowth of NSC-Derived Neurons
Images were captured from ten randomly selected fields 
per slide with a 20× objective; 500 cells were counted, and 
images were analysed using Image Pro plus 6.0 software 
(Media Cybernetics, Silver Spring, MD, USA). Percentages 
of differentiated cells were calculated by counting the num-
ber of marker-positive cells and total DAPI-stained cells. 
For neurite assays, the following parameters were meas-
ured among NSC-derived β-III-tubulin-positive neurons (as 
shown in Fig. 1): number of primary neurites and branches, 
number of neurites, number of branch points, longest neu-
rite length, and total neurite length. A neurite is defined as 
any process longer than two cell diameters in length [5]; 
a primary neurite is defined as the neurite that originates 
from the cell body; a branch is defined as the neurite that 
originates from a primary neurite [34]; a branch point is 
defined as the point at which a branch originates from a 
primary neurite or another branch [34]. To prevent exam-
iner bias, experiments were performed independently and 
repeated by three persons who were unaware of the others’ 
research results.
Western Blot
Western blot analysis was performed as described previ-
ously [35], with slight modifications. Briefly, cells were 
lysed on ice with radioimmunoprecipitation (RIPA) lysis 
buffer supplemented with protease inhibitor cocktail 
(Roche, Indianapolis, IN, USA) and sonicated to reduce 
sample viscosity. Protein concentration was determined 
using the bicinchoninic acid assay (Pierce, Rockford, IL, 
USA), equal amounts of protein were separated on 10% 
SDS-polyacrylamide gels and transferred to polyvinylidene 
difluoride (PVDF) membranes (Millipore). Western blot-
ting was performed using the following antibodies at 4 °C 
overnight: rabbit anti-β-III-tubulin (1:5000; Covance); 
rabbit anti-MAP-2 (1:2000; Millipore); rabbit anti-GFAP 
(1:5000; Abcam); rabbit anti-CNPase, rabbit anti-JNK, 
rabbit anti-p-JNK, rabbit anti-c-Jun, rabbit anti-p-c-Jun-
ser63, and rabbit anti-p-c-Junser73 (all 1:1000; all from Cell 
Signaling Technology); and mouse anti-β-actin (1:10,000; 
Sigma-Aldrich). Blots were incubated with horseradish 
peroxidase-labelled secondary anti-rabbit and anti-mouse 
antibodies, and immunoreactive bands were visualized 
on film by enhanced chemiluminescent substrate (Pierce, 
Rockford, IL, USA) (all 1:10,000, Abcam). Western blots 
were quantified with ImageJ software from three independ-
ent experiments. The intensities of the bands were normal-
ized to β-actin.
Quantitative Real-Time PCR
The procedure was performed as described previously 
[36]. Total RNA was extracted from cells with TRIzol 
reagent (Beijing Solarbio Science & Technology Co), 
and 1 μg of total RNA was transcribed into cDNA using 
a first-strand cDNA synthesis kit (Thermo Scientific, 
USA) according to the manufacturer’s protocol. qRT-
PCR was performed on a  LightCycler® 96 System (Roche 
Applied Science, Mannheim, Germany) using a  SYBR® 
Select Master Mix (Applied Biosystems, Foster City, 
CA, USA). qRT-PCR amplification was performed for 
40 cycles using the following thermal profile: denatura-
tion at 95 °C for 15  s, annealing and extension at 60 °C 
for 1 min. GAPDH was used as an internal control, and 
fold-changes obtained from three independent experi-
ments were determined using the  2−ΔΔCT method [39]. 
Fig. 1  Quantitative assessment of neurite outgrowth. Primary neu-
rites (blue) are processes that originate from the cell body and are 
numbered 1–7; the longest neurite is labelled as number 1. Branches 
(pink) are processes that originate from a primary neurite. Branch 
point (green) is the point at which a branch originates from a primary 
neurite or another branch. (Color figure online)
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PCR forward (F) and reverse (R) primers (5′-3′) were as 
follows: β-III-tubulin (F) CAA TGA GGC CTC CTC TCA 
CAA, (R) ATA GTG CCC TTT GGC CCA G; MAP-2 (F) 
GCC AGC CTC AGA ACA AAC AG, (R) AAG GTC TTG 
GGA GGG AAG AAC; GFAP (F) TCA ACG TTA AGC 
TAG CCC TGG, (R) CCC CTT CTT TGG TGC TTT TGC; 
CNPase (F) TTT ACC CGC AAA AGC CAC ACA; (R) CAC 
CGT GTC CTC ATC TTG AAG; BDNF (F) CTG AAG GCG 
TGC GAG TAT TA, (R) AGT CTT TGG TGG CCG ATA TG; 
GDNF(F) CAG GGA ACT GTG TCT TCC TTAC, (R) CCC 
TCT AGA AGC AAA GGC TAAA; CDNF (F) GGA GAG 
AGG ATG TGT GCA TTAG, (R) CCA ACT GTG GGA GGA 
AGA ATAA; and GAPDH (F) AGG TCG GTG TGA ACG 
GAT TTG, (R) GTA GAC CAT GTA GTT GAG GTCA.
Statistical Analysis
All experiments were reproduced in triplicate. All values 
were presented as the mean ± standard error of the mean 
(SEM). Quantitative data were analysed using GraphPad 
Prism 5.0 (GraphPad Software Inc., San Diego, CA, USA), 
with Student’s t test, χ2 test or one-way analysis of variance 
(ANOVA) and the Bonferroni post hoc test. Statistical sig-
nificance was set at p < 0.05.
Fig. 2  The growth and identification of mouse embryonic NSCs. 
Mouse embryonic NSCs cultured in growth medium proliferated and 
formed neurospheres on the second day after primary culture. a Phase 
contrast micrographs of 1-day culture of mouse NSC neurospheres. 
b Phase contrast micrographs of 3-day culture of mouse NSC neu-
rospheres. c Phase contrast micrographs of 5-day culture of mouse 
NSC neurospheres. d Mouse embryonic NSCs in neurospheres were 
stained by immunocytochemistry for nestin. Scale bar 100 μm
Fig. 3  Mouse embryonic NSCs differentiate into different types of neural cells. NSCs were seeded onto PLL-coated plates, cultured in differen-
tiation medium up to 7 days, and immunostained for β-tubulin-III (a), GFAP (b), and CNPase (c). Scale bar 100 μm
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Results
NSCs can Proliferate and Differentiate into Different 
Types of Neural Cells
We isolated NSCs from the brains of E13.5 mouse 
embryos. On the second day after primary culture, cells 
cultured in growth medium proliferated and formed neu-
rospheres (Fig.  2a), and neurospheres continued to pro-
liferate when maintained in growth medium (Fig. 2b, c). 
All of the neurospheres showed strong immunoreactivity 
to nestin (Fig.  2d). To differentiate NSCs, third-passage 
neurospheres were dissociated, transferred to coverslips 
coated with PLL, and then cultured in differentiation 
medium for up to 7  days; these cells differentiated into 
β-III-tubulin-positive neurons (Fig.  3a), GFAP-positive 
astrocytes (Fig.  3b), and CNPase-positive oligodendro-
cytes (Fig. 3c). These results confirm that we successfully 
isolated NSCs that differentiated into neurons, astrocytes 
and oligodendrocytes.
Fig. 4  Mouse embryonic NSCs 
were treated with 1 mM VPA 
for up to 7 days and immu-
nostained with anti-β-tubulin-
III, anti-MAP-2, anti-CNPase, 
and anti-GFAP. Scale bar 
100 μm
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VPA Treatment Mediated Improved Neuronal 
Differentiation of Mouse Embryonic NSCs
To evaluate whether VPA might influence the capacity of 
mouse NSCs to differentiate into neurons, mouse NSCs 
were dissociated into single cells, cultured in differen-
tiation medium and treated with 1  mM VPA for 7  days. 
In the VPA-treated cultures, 41.20 ± 1.19% of all cells 
were β-III-tubulin-positive (Figs.  4, 5a), exceeding that 
observed in DMSO-treated control cultures (18.80 ± 1.08%, 
p < 0.01) (Figs.  4, 5a; χ2 test, p < 0.05). Similarly, a sig-
nificant increase in the VPA-treated cultures (31.00 ± 1.08 
vs 11.60 ± 1.06%) was obtained using MAP-2 antibodies 
(Figs.  4, 5a; χ2 test, p < 0.05). The number of astrocytes 
decreased in the VPA-treated cultures (43.80 ± 1.05%) 
compared with the DMSO-treated control cultures 
(72.90 ± 1.06%) (Figs.  4, 5a; χ2 test, p < 0.05). Moreover, 
the number of oligodendrocytes was not affected by VPA 
(Figs. 4, 5a; χ2 test, p > 0.05).
Furthermore, western blot and qRT-PCR were con-
ducted to confirm the results of the immunocytochemical 
analyses. The protein and gene expression levels of β-III-
tubulin and MAP-2 increased significantly in VPA-treated 
cultures compared with DMSO-treated control cultures 
(Fig.  5b–d, t test, p < 0.05), whereas the protein and gene 
expression levels of GFAP decreased significantly in VPA-
treated cultures compared with DMSO-treated control cul-
tures (Fig. 5b–d, t test, p < 0.05). Moreover, the protein and 
gene expression levels of CNPase remained unchanged 
(Fig.  5b–d, t test, p > 0.05). Collectively, these data dem-
onstrate that VPA treatment promoted mouse NSCs to pre-
dominantly differentiate into neurons.
VPA Treatment Mediated improved Neurite Outgrowth 
in Mouse Embryonic NSC-Derived Neurons
Neurite outgrowth was assessed on day 7 in VPA-
induced NSC-derived neurons immunostained with β-III-
tubulin, and relevant parameters were measured as Fig.  1 
shown. The results showed that the neurite outgrowth 
of VPA-treated NSC-derived neurons was significantly 
increased compared with DMSO-treated control cultures, 
including number of branches (Fig.  5e; 2.10 ± 0.384 vs. 
0.80 ± 0.20; t test, p < 0.05), number of neurites (Fig.  5e; 
3.60 ± 0.31 vs. 2.00 ± 0.21; t test, p < 0.05), number of 
branch points (Fig.  5f; 1.90 ± 0.28 vs. 0.70 ± 0.21; t test, 
p < 0.05), longest neurite length (Fig.  5g; 71.89 ± 6.42 
vs. 39.51 ± 3.86 μm; t test, p < 0.05) and total neurite 
length (Fig. 5g; 253.43 ± 9.53 vs. 118.85 ± 9.48 μm; t test, 
p < 0.05), whereas no difference was observed in the num-
ber of primary neurites (Fig. 5e; 2.4 ± 0.22 vs. 1.80 ± 0.20; 
t test, p > 0.05). Collectively, these data demonstrate that 
VPA treatment promoted the neurite outgrowth of NSC-
derived neurons.
JNK Activation was Involved in the VPA-Mediated 
Improvement in Neuronal Differentiation of NSCs 
and Neurite Outgrowth of NSC-Derived Neurons
First, the expression of JNK and c-Jun was detected. As 
shown in Fig. 6, by day 7, the phosphorylation of JNK-c-
Jun was enhanced (one-way ANOVA followed by Bonfer-
roni post-test, both p < 0.05), whereas no change in the total 
JNK-c-Jun protein levels (one-way ANOVA, p > 0.05) was 
observed over the VPA-induced neuronal differentiation 
process. This result indicates that JNK may be an essential 
component in the control of the neuronal differentiation of 
NSCs and neurite outgrowth of NSC-derived neurons.
Furthermore, to investigate the involvement of JNK in 
VPA-mediated neuronal differentiation of NSCs and neur-
ite outgrowth of NSC-derived neurons, SP600125 (10 μM), 
a selective JNK inhibitor, was applied to block phospho-
rylation of JNK. As shown in Fig.  6, SP600125 resulted 
in a significant decrease in phosphorylated JNK-c-Jun 
(one-way ANOVA followed by the Bonferroni post-test, 
both p < 0.05). Moreover, the VPA-mediated increased pro-
portions of β-III-tubulin- and MAP-2-positive cells were 
largely reduced in the presence of SP600125, whereas the 
percentage of GFAP-positive cells increased (Figs. 7, 8a; χ2 
test, all p < 0.05). Similar results were obtained from qRT-
PCR: β-III-tubulin and MAP-2 gene expression decreased, 
whereas GFAP gene expression increased, CNPase gene 
expression remained unchanged (Fig. 8b; one-way ANOVA 
followed by the Bonferroni post-test, all p < 0.05). Moreo-
ver, gene expression levels of BDNF, GDNF, and CDNF 
increased significantly in VPA-treated cultures com-
pared with DMSO-treated control cultures, whereas they 
all decreased significantly in the presence of SP600125 
(Fig.  8c; one-way ANOVA followed by the Bonferroni 
post-test, all p < 0.05).
Moreover, immunocytochemical analysis of β-III-
tubulin demonstrated that SP600125 reduced the VPA-
mediated increase in neurite outgrowth, including number 
Fig. 5  VPA promotes the neuronal differentiation of mouse embry-
onic NSCs and the neurite outgrowth of NSC-derived neurons. 
a Summary of proportions of mouse embryonic NSC-derived 
β-tubulin-III-, MAP-2-, CNPase-positive cells, and GFAP-positive 
cells. b Western blot analysis of β-tubulin-III and GFAP. β-actin pro-
tein levels were used as a loading control. c Summary of the quanti-
fication of β-tubulin-III, MAP-2, CNPase, and GFAP levels. d Sum-
mary of the quantification of β-tubulin-III, MAP-2, CNPase, and 
GFAP gene expression. e Quantification of the number of primary 
neurites and branches and the number of neurites. f Quantification of 
the number of branch points. g Quantification of the longest neurite 
length and total neurite length. *p < 0.05 compared with the DMSO-
treated control cultures; #p > 0.05 compared with the DMSO-treated 
control cultures
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of branches, number of neurites, number of branch points, 
longest neurite length, and total neurite length of NSC-
derived neurons (Fig. 8c–e; one-way ANOVA followed by 
the Bonferroni post-test, all p < 0.05).
Together, these results implied that JNK activation plays 
a crucial role in the VPA-induced neuronal differentiation 
of mouse embryonic NSCs and the neurite outgrowth of 
NSC-derived neurons.
Discussion
Here, we successfully obtained NSCs from the embryonic 
mouse forebrain cortex, and we demonstrated that VPA 
treatment enhanced neuronal differentiation of mouse 
embryonic NSCs and neurite outgrowth of NSC-derived 
neurons over differentiation conditions. Particularly, we 
showed that JNK activation participates in these processes.
CNS injuries are mainly caused by the progressive death 
or damage of neurons [19, 37, 38]. NSC transplantation can 
replace damaged or lost neurons via the ability of NSCs 
to differentiate into neurons [3, 37, 39]. Therefore, NSCs 
are excellent candidates for stem cell-based therapies for 
CNS injuries [2–4]. In NSC-based therapy, neuronal dif-
ferentiation is an important step in the regeneration and 
replacement of neurons and neural networks [33]. In addi-
tion, neurite outgrowth, a key cellular aspect of neuronal 
differentiation, is important for neural plasticity and synap-
tic formation [6]. Based on these findings, we investigated 
whether VPA can increase the neuronal differentiation of 
mouse embryonic NSCs and neurite outgrowth of NSC-
derived neurons.
VPA, an anticonvulsant and mood stabilizer, is safe and 
effective and has broad pharmacological effects, such as 
inducing apoptosis, inhibiting proliferation, and increas-
ing tumour cell immunogenicity [12–14]. Importantly, 
VPA exerts more divergent and complex actions in the 
nervous system, where it upregulates neurotrophic fac-
tors, such as brain-derived neurotrophic factor (BDNF) 
and glial cell line-derived neurotrophic factor (GDNF), 
in astrocytes [40–42]; VPA treatment enhances the neu-
ronal differentiation of haematopoietic stem cells, bone 
marrow-derived MSCs, sympathoadrenal progenitor cells, 
adult female Fisher 344 rats hippocampal NPCs, embry-
onic Sprague–Dawley rat-derived NPCs, 46C mouse 
ESC-derived NPCs, adult spinal NSPCs from SCI rats, 
and rat embryonic NSCs [16–21, 43–45]. Moreover, VPA 
increased the neurite outgrowth of SH-SY5Y neuroblas-
toma cells, human hippocampal cultures, and MSCs [21, 
22, 46]. Additionally, Abematsu and colleagues recently 
found that VPA administration significantly enhanced 
the differentiation of transplanted NSCs into neurons in 
SCI mice [47]. Therefore, we hypothesized that VPA can 
improve the neuronal differentiation of mouse embryonic 
NSCs and neurite outgrowth of NSC-derived neurons. 
Indeed, our study demonstrated that VPA increased the 
percentage of β-III-tubulin- or MAP-2-positive neurons. 
However, a previous study has found that VPA-treated mice 
Fig. 6  Effect of VPA on of p-JNK, t-JNK, p-c-Junser63, p-c-Junser73 
and t-c-Jun protein levels. a Western blot analysis of p-JNK, t-JNK, 
p-c-Junser63, p-c-Junser73 and t-c-Jun. β-actin protein levels were used 
as a loading control. b Summary of the quantification of p-JNK/t-
JNK protein levels. c Summary of the quantification of p-c-Junser63/t-
c-Jun and p-c-Junser73/t-c-Jun protein levels. *p < 0.05 compared with 
the DMSO-treated control cultures
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(300 mg/kg) have a decreased level of postnatal neurogen-
esis in the hippocampus, this is presumably due to a slower 
differentiation of the residual NPCs caused by deple-
tion of the NPC pool [48]. These seemingly contradictory 
findings could imply that VPA-mediated various effects 
might depend on the cell type, context of VPA usage, and 
experimental design used. Meanwhile, the effects of VPA 
on neurite length of NSC-derived neurons were assessed, 
including number of branches, number of neurites, number 
of branch points, longest neurite length, and total neurite 
length. Number of branches and number of neurites are 
semi-quantitative parameters which do not result in a cali-
brated measure of neurite length; while number of branch 
points, longest neurite length, and total neurite length are 
quantitative parameters which provide a calibrated measure 
for some aspect of neurite length [34]. Therefore, our exper-
iments successfully confirmed that VPA increased the neu-
rite length of NSC-derived neurons. Moreover, coincident 
with the idea that CDNF and GDNF mRNA expressions in 
C17.2 neural stem cells were upregulated by 0.5 or 1.0 mM 
VPA [40], our results further confirmed that 1.0 mM VPA 
increased BDNF, GDNF and CDNF level significantly. 
In addition, a serum VPA concentration of 0.3–1  mM is 
commonly used for the long-term treatment of epilepsy or 
mood disorders [12, 46], and several lines of evidence have 
demonstrated that 1 mM is a desirable concentration for the 
Fig. 7  Mouse embryonic NSCs were treated with 1 mM VPA for up to 7 days in the absence or presence of 10 µM SP600125 and immu-
nostained with anti-β-tubulin-III, anti-MAP-2, anti-CNPase, and anti-GFAP. Scale bar 100 μm
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neuronal differentiation of NPCs [16–18]. Therefore, in this 
experiment, we chose 1  mM VPA to treat mouse embry-
onic NSCs. However, the molecular mechanism by which 
VPA exerts its effects in mouse embryonic NSCs needs to 
be clarified.
JNK plays an important role in the neuronal differen-
tiation or neurite outgrowth of several cell lines, includ-
ing dopaminergic neurons, PC12 cells, P19 embryonal 
carcinoma cells, human neuroblastoma SH-SY5Y cells, 
and N1E-115 neuroblastoma cells [30, 31, 49–51]. JNK 
can be activated by a variety of physical and chemical 
stresses, such as osmotic stress, redox stress, heat shock, 
or UV irradiation [23, 24]; moreover, neurotrophic fac-
tors and cytokines can stimulate the JNK signalling 
cascade. JNK phosphorylation is required for the NGF-
mediated neuronal differentiation of PC12 cells [26], the 
Fig. 8  SP600125 decreased the VPA-mediated increase in the neu-
ronal differentiation of mouse embryonic NSCs and the neurite out-
growth of NSC-derived neurons. a Summary of the proportions of 
mouse embryonic NSCs-derived β-tubulin-III-, MAP-2-, CNPase-
positive cells, and GFAP-positive cells. b Summary of the quantifi-
cation of β-tubulin-III, MAP-2, CNPase, and GFAP gene expression. 
c Summary of the quantification of BDNF, GDNF and CDNF gene 
expression. d Quantification of the number of primary neurites and 
branches and the number of neurites. e Quantification of the number 
of branch points. f Quantification of longest neurite length and total 
neurite length. *p < 0.05 compared with the VPA-treated control cul-
tures; #p > 0.05 compared with the VPA-treated control cultures; ##p 
> 0.05 compared with the VPA-treated control cultures
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IFN-γ-mediated neuronal differentiation of NPCs [52], 
and the RA-induced differentiation of MN9D dopamin-
ergic neuronal cells, as well as the spontaneous neurite 
outgrowth of dopaminergic neurons [30]. Meanwhile, 
VPA acts as a neurotrophic growth factor and exerts a 
variety of neurotrophic effects by enhancing neurogen-
esis, protecting neurons, and promoting differentiation 
[21, 44, 46]. In addition, a recent study demonstrated 
that VPA induces the neurite outgrowth of mouse neu-
roblastoma N1E-115 cells through a JNK-paxillin unit 
[31]. Together, these findings raise the possibility that 
JNK activation is required in the VPA-mediated neu-
ronal differentiation of NSCs and neurite outgrowth of 
NSC-derived neurons. To verify this hypothesis, we 
applied the JNK inhibitor SP600125, which is an efficient 
and specific inhibitor of the JNK that can significantly 
inhibit the activation/phosphorylation of JNK [53, 54]. In 
the present study, we showed that the increase in β-III-
tubulin- and MAP-2-positive cells mediated by VPA 
decreased significantly in the presence of SP600125. This 
result is consistent with the majority of previous findings 
showing that SP600125 can decrease the proportions of 
β-III-tubulin-positive cells [17, 18]. Meanwhile, in our 
study, we showed that SP600125 decreased the increased 
neurite outgrowth of NSC-derived neurons stimulated 
by VPA, which is consistent with previous studies dem-
onstrating that SP600125 nearly abolished neurite out-
growth in cultured ES cell-derived neurons and N1E-115 
cells [5, 31, 55]. Moreover, the increased BDNF, GDNF 
and CDNF level regulated by VPA decreased signifi-
cantly in the presence of SP600125. Collectively, these 
results imply that JNK activation is involved in the VPA-
mediated neuronal differentiation of NSCs and neurite 
outgrowth of NSC-derived neurons.
The JNK family consists of JNK1, JNK2, and JNK3. 
JNK1 and JNK2, which are widely expressed in a variety 
of tissues, are involved in the regulation of neurite out-
growth in spiral ganglion neurons, dorsal root ganglion 
neurons and PC12 cells [29, 56]; whereas JNK3, which is 
highly expressed in CNS neurons, the heart, and the testis 
[57, 58], contributes to the maturation of ES cell-derived 
cortical neuronal cells and controls the neurite outgrowth 
of midbrain dopaminergic neurons [59]. Clearly, we sus-
pect these three isoforms to have differential effects on 
the neuronal differentiation of NSCs and neurite out-
growth of NSC-derived neurons; therefore, further stud-
ies should investigate the mechanism of each JNK iso-
form in the neuronal differentiation of NSCs and neurite 
outgrowth of mouse NSC-derived neurons. Moreover, 
several previous studies have demonstrated that HDAC, 
GSK-3, and Wnt are involved in the VPA-mediated neu-
ronal differentiation of NPCs [45, 60]; it will be of inter-
est to explore these mediators in VPA-mediated neuronal 
differentiation and neurite outgrowth of mouse NSC in a 
future study.
In summary, this study demonstrates that VPA improves 
the neuronal differentiation of mouse NSCs and neurite 
outgrowth of NSC-derived neurons; moreover, JNK activa-
tion was involved in the effects of VPA stimulation.
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